These findings aligned with previous studies that identified EIF4E as an oncogenic factor in various cancers, where it promoted tumour progression by enhancing specific mRNA translation processes in cell growth and survival [48, 49, 50, 51, 52]. The gene discussed is EIF4E; the disease is cancer.